1:08:53

Latest Advancements in Antibody Engineering – Bispecifics, Diagnostic Controls, and More

1:01:08

Comparing Bispecific Antibody Format Feasibility

1:08:32

Treating Lymphoma with Bispecific Antibodies | LRF Webinars

1:15:12

Innovations from the therapeutics antibody space: obligate bispecific antibodies & T cell engagers

46:47

Bispecific Antibody Overview & Production with CrossMab Technology

32:12

Immunogenicity causing Antidrug Antibodies: How, Why, Which cells, What and When?

55:53

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology

55:50

Target selectivity of multispecific antibodies: practical analysis of binding kinetics and avidity